ARVN Arvinas, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:42
Sep 09
Sep 09
15% weight in AI biotech portfolio
Arvinas is assigned a 15% weight in the author's AI-screened biotech portfolio, based on clinical stage, approval probability, market size and cash runway criteria. The bet is on the company's targeted protein degradation pipeline reaching key milestones. Main risk is the AI analysis overlooking bear-case assumptions and the concentrated portfolio construction.
MED
About ARVN Analyst Coverage
Buzzberg tracks ARVN (Arvinas, Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: u/board_meeting45.